DAVIS, CA – September 25, 2017 – Marrone Bio Innovations, Inc. (NASDAQ: MBII), (MBI) a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and water treatment markets, has announced the availability of Venerate XC bioinsecticide in New York.

Venerate XC is a liquid microbial-based, contact and ingestion insecticide that degrades insect exoskeletons and interferes with molting of chewing insects, nymphs and adult sucking insects, as well as with flies and mites.

Lisa Malabad, MBI’s Insecticide and Nematicide Product Manager, said: “We are pleased that MBI is now able to provide New York growers with a second bioinsecticide for their pest management tool box. Venerate XC has been available in other states since 2015 and has consistently demonstrated cost-effective control of a variety of chewing and sucking insects and mites. Key fruit pests in New York targeted by Venerate XC include San Jose scale, rosy apple aphid, pear psylla and grape berry moth on apple, pear and grape crops. Today, New York growers now have access to a new insecticide with novel modes of action.”

Venerate XC, a user-friendly liquid formulation, is approved for use on a wide variety of New York’s vegetable, vine and tree fruit crops in conventional integrated pest management (IPM) and organic systems. Venerate has a minimal four hour re-entry interval (REI) as well as the advantage of a zero-day pre-harvest interval (PHI) and an exemption from MRL (maximum residue level) tolerances—a measure of pesticide residue limits that must be met for most food crop exports. There is no limit to the number of applications allowed per season, unlike many chemical products that have high risk for pest resistance development or trigger pesticide residue concerns. The product is also non-toxic to fish, birds, and most beneficial insects including honeybees.

With a unique mode of action, Venerate XC is an effective addition to a conventional IPM program for managing pest resistance. When used along with MBI’s other bioinsecticide, Grandevo, a broad-spectrum insecticide, New York farmers now have two bioinsecticides to manage key pests and reduce chemical residues, while reducing the risk of insecticide resistance.

All MBI products should be used in accordance with label directions.

About Marrone Bio Innovations
Smart. Natural. Solutions.

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI currently has six commercially available products (Regalia®, Grandevo®, Venerate®, Majestene®, Haven™ and Zequanox®) as well as eight product candidates in various stages of the company’s rapid development pipeline. MBI also distributes Bio-tam 2.0® for Isagro USA in the western U.S. and Jet-Ag® for Jet Harvest in most regions of the U.S.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers and consumers around the globe. For more information, please visit www.marronebio.com.

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding sales of the Company’s products, the potential benefits of the Company’s products, and MBI’s efforts with respect to expansion of its product labels in international markets. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, any difficulty in marketing MBI’s products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, and adverse decisions by regulatory agencies and other relevant third parties. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Marrone Bio Innovations Contacts:
Bielinski Santos, Field Development and Technical Services Manager
Telephone: +1 (530) 750-2800
Email: Info@marronebio.com

Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449